Andrew Enrietti serves as the Chief Administrative and Transformation Officer at Viatris Inc., a global healthcare company formed by the merger of Mylan N.V. and Pfizer’s Upjohn business. In this pivotal role, he oversees enterprise-wide transformation initiatives, administrative functions, corporate real estate, global security, and sustainability efforts. Enrietti leads cross-functional teams to drive operational efficiency, integrate post-merger systems, and advance Viatris’s strategic priorities, including digital transformation and ESG commitments. His leadership has been instrumental in streamlining global operations across more than 160 countries, ensuring seamless execution amid complex regulatory landscapes. With over 25 years of experience in the pharmaceutical and healthcare industries, Enrietti’s career trajectory includes senior leadership positions at Mylan, where he rose to Senior Vice President and Chief Administrative Officer, managing global facilities, procurement, and transformation programs. Prior to Mylan, he held key roles at Pfizer Inc., including Global Head of Corporate Real Estate Services and leadership in supply chain optimization. His expertise in large-scale mergers, cost-saving initiatives, and infrastructure modernization has delivered multimillion-dollar efficiencies and fostered innovative workplace strategies. Enrietti’s achievements include spearheading Viatris’s post-merger integration, which unified disparate systems and reduced overhead costs by optimizing real estate footprints worldwide. A recognized leader in sustainable business practices, he has championed initiatives that align corporate strategy with environmental goals, earning accolades from industry peers. Under his guidance, Viatris continues to evolve as a resilient, patient-centric organization poised for long-term growth.